Pricing, Reimbursement & Access Manager at Eli Lilly and Company

Bogotá, Bogota, Colombia

Eli Lilly and Company Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Accountability: Takes ownership for decisions, outcomes, and continuous improvement
  • Learning Agility: Quickly learns from new or challenging situations; adapts flexibly to changing conditions
  • Grit: Demonstrates perseverance and focus on achieving long-term goals despite obstacles
  • Curiosity: Thinks critically, asks insightful questions, and seeks continuous learning
  • Emotional Intelligence: Uses self-awareness and empathy to manage relationships effectively
  • Motivational Fit / Passion for Work: Shows commitment to patient value and excellence in execution
  • Adaptability: Maintains effectiveness in dynamic, evolving environments
  • Desirable: Strategic analysis and planning
  • Desirable: Negotiation and influence
  • Desirable: Problem solving and innovation
  • Desirable: Business and financial acumen
  • Desirable: Decision-making under ambiguity
  • Desirable: Cross-functional coordination
  • Desirable: Project management and prioritization
  • Desirable: Effective communication
  • Desirable: Leading and influencing without authority
  • Desirable: Service orientation

Responsibilities

  • Lead the development and execution of payer, reimbursement, and access strategies to optimize patient access and ensure sustainable reimbursement for Lilly brands, in alignment with the company’s global framework and local healthcare environment
  • Demonstrate deep understanding of the local healthcare system, including key decision-making bodies and the PRA/HTA process
  • Identify and analyze key stakeholders at national, regional, and local levels, understanding their needs, behaviors, and perspectives
  • Interpret healthcare environment factors and trends that influence the management of patients across disease areas
  • Evaluate market dynamics and payer trends to anticipate opportunities and risks that may impact brand performance and access
  • Understand disease characteristics, current standards of care, and patient pathways to identify unmet needs from both patients and payers
  • Analyze and apply clinical data from Lilly brands to identify opportunities for real-world evidence generation that supports payer value
  • Monitor competitor actions and therapeutic landscape to anticipate their potential impact on the PRA success of Lilly brands
  • Use insights to inform early commercialization and pricing strategies throughout the product lifecycle
  • Develop and communicate evidence-based payer value propositions that align with the brand strategy and value messaging framework
  • Lead cross-functional collaboration to develop integrated payer strategies that ensure consistency between PRA, marketing, and medical priorities
  • Prepare evidence-based dossiers, materials, and value stories that effectively communicate the value of Lilly brands to payers
  • Support the implementation of value-based agreements and risk-sharing initiatives grounded in data and payer insights
  • Build trusted relationships with key internal and external stakeholders, including payers, trade associations, and advocacy organizations
  • Ensure timely and transparent delivery of PRA-related initiatives, maximizing synergies and efficiencies across teams
  • Coordinate with global and IBU PRA colleagues to share learnings and best practices
  • Apply omnichannel engagement tools (OCE) to ensure consistent, compliant, and impactful payer communication
  • Define and track performance metrics to measure the effectiveness of PRA strategies and customer experience outcomes

Skills

Payer Strategy
Reimbursement
Market Access
HTA Process
Stakeholder Analysis
Healthcare Policy
Pricing Strategy
Real-World Evidence
Competitor Analysis
Value Proposition

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI